000			03494nam a22005295i 4500
001			978-1-60761-166-0
003			DE-He213
005			20140220083734.0
007			cr nn 008mamaa
008			101216s2011 xxu| s |||| 0|eng d
020			_a9781607611660 _9978-1-60761-166-0
024	7		_a10.1007/978-1-60761-166-0 _2doi
050		4	_aRC254-282
072		7	_aMJCL _2bicssc
072		7	_aMED062000 _2bisacsh
082	0	4	_a616.994 _223
100	1		_aNorden, Andrew D. _eeditor.
245	1	0	_aPrimary Central Nervous System Tumors _h[electronic resource] : _bPathogenesis and Therapy / _cedited by Andrew D. Norden, David A. Reardon, Patrick C. Y. Wen.
264		1	_aTotowa, NJ : _bHumana Press, _c2011.
300			_aXIV, 570 p. _bonline resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
490	1		_aCurrent Clinical Oncology
505	0		_aPart I: General Principles -- 1 - Epidemiology and Risk Factors -- 2 - Molecular Pathogenesis -- 3 - Brain Tumor Stem Cells -- 4 - Principles of Supportive Care -- 5 - Principles of Clinical Trial Design and Response Assessment -- 6 - Complications of Therapy -- 7 – Neuropsychological Function and Quality of Life -- Part II: Gliomas -- 8 - Low-Grade Gliomas -- 9 - High-Grade Astrocytomas -- 10 - Anaplastic Oligodendrogliomas and Mixed Gliomas -- 11 - Ependymomas -- 12 - Uncommon Gliomas in Adults: Brainstem Gliomas, Pilocytic Astrocytomas and Pleomorphic Xanthoastrocytomas -- Part III: Other Tumor Types -- 13 - Pediatric Tumors -- 14 - Primary Central Nervous System Lymphoma -- 15 - Meningiomas -- 16 - Pituitary Adenomas -- 17 - Vestibular Schwannomas -- 18 - Medulloblastomas -- 19 - Pineal Region Tumors -- 20 - Genetic Syndromes -- 21 - Rare Tumors -- 22 - Spinal Tumors.
520			_aThis comprehensive, yet practical, text is a ready collection of the most up-to-date information on primary CNS tumors. Authored by a carefully selected group of the world’s leading clinicians and scientists, the book is divided into three sections. The opening chapters cover general principles, including epidemiology, pathogenesis, tumor stem cells, supportive care, complications of therapy, and quality of life. The remaining two sections are comprised of treatment-oriented chapters covering the spectrum of gliomas and rarer tumor types. Each of these chapters presents multi-disciplinary therapeutic approaches and addresses specific disease concerns. Throughout, the authors incorporate the cutting-edge advances in molecular biology and genomics that are revolutionizing neuro-oncology. The result is an important clinical resource which provides evidence-based data and interpretation essential to intelligent therapeutic decision making.
650		0	_aMedicine.
650		0	_aRadiotherapy.
650		0	_aNeurology.
650		0	_aNeurosurgery.
650		0	_aOncology.
650	1	4	_aMedicine & Public Health.
650	2	4	_aOncology.
650	2	4	_aNeurosurgery.
650	2	4	_aNeurology.
650	2	4	_aRadiotherapy.
700	1		_aReardon, David A. _eeditor.
700	1		_aWen, Patrick C. Y. _eeditor.
710	2		_aSpringerLink (Online service)
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9781607611653
830		0	_aCurrent Clinical Oncology
856	4	0	_uhttp://dx.doi.org/10.1007/978-1-60761-166-0
912			_aZDB-2-SME
999			_c106350 _d106350